Skip to content
AnalystLens

CHURCH & DWIGHT CO INC /DE/ Quarterly Report for Q2 Ended Apr 2, 2004

Filing Date
Filed May 12, 2004
Period End
April 2, 2004
Security
CHD
In the record · 2016–202610-K1110-Q328-K103

CHD filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 103 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Aug ’19Aug ’19
  3. Leadership change8-K · Sep ’21Sep ’21
  4. Material agreement8-K · Jul ’25Jul ’25

Summary

Summary of the 10-Q filed May 12, 2004. Cited figures are marked; the original filing is the authoritative source.

Church & Dwight Co., Inc. (CHD) reported a strong first quarter ended April 2, 2004, with significant year-over-year growth in net sales and net income.

Net sales increased by 19.2% to $296 milliona, driven by the acquisition of the former Unilever oral care business and organic growth across key segments. Net income more than doubled to $29.9 million, or $0.73 per diluted share, compared to $20.9 million, or $0.50 per diluted share, in the prior year period. This robust performance was supported by an improved gross margin, partially offset by increased marketing and SG&A expenses.

An important subsequent event disclosed is the non-binding agreement to acquire the remaining 50% interest in Armkel, LLC for approximately $254 millionb, expected to close by May 30, 2004. This acquisition will be financed through new borrowing facilities and is expected to result in non-cash accounting charges in the second and third quarters.

The company maintains strong financial covenants, with its leverage ratio well within the agreed-upon limits. Overall, the quarter demonstrated significant operational momentum and strategic progress for Church & Dwight.

Key Highlights

  1. Net sales surged 19.2% to $296.0 million, aided by the acquisition of the Unilever oral care business ($30M) and favorable foreign exchange.
  2. Net income increased substantially by 42.8% to $29.9 million ($0.73/share basic, $0.70/share diluted), up from $20.9 million ($0.52/share basic, $0.50/share diluted) in the prior year.
  3. Gross margin improved to 32.6% from 29.7%, largely due to the higher-margin acquired oral care products and reduced promotional spending.
  4. The company announced a non-binding agreement to acquire the remaining 50% of Armkel, LLC for approximately $254 million, expected to close by May 30, 2004.
  5. Operating cash flow was strong at $31.1 million, supporting investments in property, plant, and equipment and debt repayments.
  6. The company's financial covenants remain robust, with a leverage ratio of 2.16x (vs. max 3.00x) and an interest coverage ratio of 6.86x (vs. min 5.0).

Frequently Asked Questions

  1. What were the main drivers of the significant increase in net sales?

    The primary driver was the acquisition of the former Unilever oral care business, contributing approximately $30 million in sales. Additionally, favorable foreign exchange rates added $1.8 million, and the company benefited from six extra days in the fiscal quarter and a reduction in trade and consumer promotion spending.

  2. How did the Armkel acquisition plan impact the company's financials?

    The company announced a non-binding agreement to acquire the remaining 50% of Armkel, LLC for approximately $254 million. This acquisition, expected to close by May 30, 2004, will be financed by new borrowing facilities. While not impacting the current quarter's results, it's noted that the transaction will lead to non-cash accounting charges in the second and third quarters.

  3. What is the outlook for gross margins and operating expenses?

    Gross margin improved due to the higher-margin acquired oral care business and reduced promotional spending. However, marketing expenses increased due to higher advertising for deodorizing and oral care products, and SG&A expenses rose due to higher selling costs, amortization from the acquired business, increased compensation, IT spending, and Sarbanes-Oxley compliance costs.

  4. What is the company's financial health based on its debt and cash flow?

    The company ended the quarter with a net debt position of $297.7 million. Operating cash flow was robust at $31.1 million, which, along with other sources, was used for capital expenditures, dividends, and debt reduction. The company's leverage and interest coverage ratios are well within the limits of its primary credit facility, indicating a healthy financial position.